[HTML][HTML] Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?

S Deleu, K Machiels, J Raes, K Verbeke, S Vermeire - EBioMedicine, 2021 - thelancet.com
The gut microbiome and the intestinal immune system are driving contributors to
inflammatory bowel diseases (IBD). Both have an important signalling factor in common …

Pathway paradigms revealed from the genetics of inflammatory bowel disease

DB Graham, RJ Xavier - Nature, 2020 - nature.com
Inflammatory bowel disease (IBD) is a complex genetic disease that is instigated and
amplified by the confluence of multiple genetic and environmental variables that perturb the …

[HTML][HTML] Therapeutic potential of vagus nerve stimulation for inflammatory bowel diseases

B Bonaz, V Sinniger, S Pellissier - Frontiers in neuroscience, 2021 - frontiersin.org
The vagus nerve is a mixed nerve, comprising 80% afferent fibers and 20% efferent fibers. It
allows a bidirectional communication between the central nervous system and the digestive …

Adipose‐derived mesenchymal stem cell‐secreted exosome alleviates dextran sulfate sodium‐induced acute colitis by Treg cell induction and inflammatory cytokine …

N Heidari, H Abbasi‐Kenarsari… - Journal of cellular …, 2021 - Wiley Online Library
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is an
inflammatory condition that results in gastrointestinal tract damage. Various factors …

ILC1 drive intestinal epithelial and matrix remodelling

GM Jowett, MDA Norman, TTL Yu, P Rosell Arevalo… - Nature materials, 2021 - nature.com
Organoids can shed light on the dynamic interplay between complex tissues and rare cell
types within a controlled microenvironment. Here, we develop gut organoid cocultures with …

Inflammatory bowel disease–non-biological treatment

F Magro, G Cordeiro, AM Dias, MM Estevinho - Pharmacological Research, 2020 - Elsevier
Nowadays, non-biological treatments remain valuable approaches among the therapeutic
armamentarium of inflammatory bowel disease (IBD). Mesalamine is the core treatment of …

Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment

CPJ Wang, MJ Byun, SN Kim, W Park, HH Park… - Journal of Controlled …, 2022 - Elsevier
Inflammatory bowel diseases (IBDs) are idiopathic gastrointestinal inflammatory disorders
featuring chronic intestinal inflammation. Although IBDs are increasingly becoming globally …

An oral pH-activated “nano-bomb” carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis

M Yang, C Yang, Y Zhang, X Yan, Y Ma, Y Zhang… - Biomaterials …, 2022 - pubs.rsc.org
Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease that features
colonic epithelial barrier dysfunction and gut dysbiosis. Preclinical studies demonstrated that …

[HTML][HTML] Human intestinal mononuclear phagocytes in health and inflammatory bowel disease

C Caër, MJ Wick - Frontiers in immunology, 2020 - frontiersin.org
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a
complex immune-mediated disease of the gastrointestinal tract that increases morbidity and …

[HTML][HTML] Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis

MT Ren, ML Gu, XX Zhou, MS Yu, HH Pan… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Sirtuin 1 (SIRT1) is a nicotinamide adenine dinucleotide (NAD+)-dependent
protein deacetylase that is involved in various diseases, including cancers, metabolic …